Profile data is unavailable for this security.
About the company
Imagion Biosystems Limited is a medical imaging company. The Company is developing a non-radioactive and precision diagnostic molecular imaging technology. Its principal activity consists of nanotechnology, biotechnology, cancer diagnostics and medical imaging using magnetic resonance. It uses bio-safe magnetic nanoparticles to detect cancer and other diseases. The Company operates through Research and Development segment. Its MagSense HER2 Imaging Agent (MSH2IA) is a first-in-class molecular imaging product candidate that is intended to detect tumors more accurately than relying solely on anatomical abnormalities seen in conventional imaging. With its tumor targeting, MSH2IA produces Magnetic resonance imaging (MRI) images that are differentiable between an abnormal lymph node and a normal node in HER2 positive breast cancer patients undergoing axillary imaging. Its PrecisionMRX products include Dextran-Coated, mPEG Coated, Oleic Acid Coated and Carboxylic Acid Functionalized.
- Revenue in AUD (TTM)1.06m
- Net income in AUD-2.20m
- Incorporated2016
- Employees--
- LocationImagion Biosystems LtdLevel 8, 55 Bourke StreetMELBOURNE 3000AustraliaAUS
- Phone+61 39692-7222
- Websitehttps://imagionbiosystems.com/
Peer analysis
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Chimeric Therapeutics Ltd | 3.97m | -10.43m | 6.63m | -- | -- | 1.61 | -- | 1.67 | -0.007 | -0.007 | 0.0028 | 0.0009 | 0.2154 | -- | 1.73 | -- | -56.62 | -66.67 | -171.92 | -112.02 | 78.66 | -- | -262.83 | -2,013.07 | -- | -62.30 | 0.7162 | -- | -- | -- | 16.76 | -- | -- | -- |
| Invion Ltd | 0.00 | -8.81m | 6.85m | 8.00 | -- | 0.823 | -- | -- | -0.1183 | -0.1183 | 0.00 | 0.0972 | 0.00 | -- | -- | -- | -70.63 | -29.16 | -77.64 | -30.88 | -- | -- | -- | -147.34 | -- | -- | 0.00 | -- | -100.00 | -- | -56.50 | -- | -- | -- |
| Nexalis Therapeutics Ltd | 837.55k | -1.33m | 7.09m | -- | -- | -- | -- | 8.46 | -0.006 | -0.006 | 0.0037 | -0.0041 | 0.8301 | -- | 2.50 | -- | -131.43 | -73.85 | -- | -100.32 | -- | -- | -158.33 | -369.19 | -- | -- | -- | -- | -66.38 | 21.67 | 16.21 | -- | -- | -- |
| Vectus Biosystems Ltd | 18.77k | -1.78m | 7.21m | -- | -- | -- | -- | 384.31 | -0.0334 | -0.0334 | 0.0004 | -0.0048 | 0.0134 | -- | 0.0266 | -- | -126.57 | -79.19 | -247.24 | -189.44 | -- | -- | -9,468.62 | -10,165.01 | 0.9301 | -554.06 | -- | -- | -75.58 | 73.61 | 23.99 | -- | -- | -- |
| Percheron Therapeutics Ltd | 371.10k | -14.92m | 7.61m | 8.00 | -- | 0.7609 | -- | 20.51 | -0.0149 | -0.0149 | 0.0004 | 0.0092 | 0.0275 | -- | 0.2824 | -- | -110.67 | -79.28 | -153.98 | -96.61 | -- | -- | -4,021.00 | -3,694.96 | -- | -1,093.50 | 0.0026 | -- | -39.71 | 64.80 | -25.19 | -- | -6.74 | -- |
| Biotron Ltd | 0.00 | -318.57k | 8.11m | 4.00 | -- | 7.21 | -- | -- | -0.0004 | -0.0004 | 0.00 | 0.0004 | 0.00 | -- | -- | -- | -43.23 | -86.63 | -206.95 | -112.69 | -- | -- | -- | -- | -- | -- | 0.00 | -- | -- | -- | 90.73 | -- | -- | -- |
| Invex Therapeutics Ltd | 473.31k | -835.91k | 9.39m | -- | -- | 2.07 | -- | 19.85 | -0.0111 | -0.0111 | 0.0063 | 0.0605 | 0.0894 | -- | 5.09 | -- | -15.79 | -15.04 | -16.83 | -15.74 | -- | -- | -176.61 | -419.12 | -- | -- | 0.00 | -- | -72.92 | 22.74 | 70.95 | -- | -- | -- |
| Adalta Ltd | 695.66k | -4.50m | 10.20m | -- | -- | -- | -- | 14.66 | -0.0059 | -0.0059 | 0.0009 | -0.0005 | 0.1804 | -- | 0.4992 | -- | -116.72 | -70.41 | -216.60 | -126.24 | -- | -- | -647.19 | -207.18 | -- | -75.41 | 1.51 | -- | -61.02 | -28.97 | 16.33 | -- | -- | -- |
| BPH Energy Ltd | 914.02k | -1.21m | 10.83m | 2.00k | -- | 0.2569 | -- | 11.85 | -0.001 | -0.001 | 0.0008 | 0.0311 | 0.0235 | -- | 8.56 | -- | -3.10 | 9.05 | -3.15 | 9.45 | -- | -- | -132.17 | 431.04 | -- | -0.8233 | 0.0022 | -- | -0.8344 | 28.34 | 48.93 | 43.33 | -- | -- |
| Imagion Biosystems Ltd | 1.06m | -2.20m | 11.28m | -- | -- | -- | -- | 10.69 | -0.0177 | -0.0177 | 0.0082 | -0.0192 | 1.45 | -- | 1,173.13 | -- | -302.58 | -76.63 | -- | -102.36 | -- | -- | -208.52 | -911.24 | -- | -0.7972 | -- | -- | -18.54 | 22.02 | 83.43 | -- | -- | -- |
| Cambium Bio Ltd | 670.05k | -3.84m | 12.06m | -- | -- | 5.23 | -- | 18.00 | -0.3489 | -0.3489 | 0.0596 | 0.1004 | 0.1498 | -- | 2.58 | -- | -85.96 | -41.30 | -146.56 | -75.44 | 70.04 | -- | -573.73 | -118.71 | -- | -- | 0.2082 | -- | 419.43 | -16.63 | -70.42 | -- | -- | -- |
| Nexsen Ltd | -100.00bn | -100.00bn | 16.70m | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | 47.44 | -- | -605,140.90 | -- | -- | -- |
| Neurotech International Ltd | 2.58m | -10.60m | 16.85m | -- | -- | 4.62 | -- | 6.53 | -0.0103 | -0.0103 | 0.0025 | 0.0028 | 0.3341 | -- | 12.69 | -- | -137.17 | -130.68 | -142.71 | -148.27 | 4.41 | -- | -410.57 | -428.93 | 11.34 | -- | 0.00 | -- | -22.61 | 99.30 | -109.08 | -- | -- | -- |
